U.S. Probes High Generic Drug Prices
The U.S. government is investigating whether the consolidation of health insurers, pharmacy benefit managers and pharmacies is fueling high drug costs. The Departm
The U.S. government is investigating whether the consolidation of health insurers, pharmacy benefit managers and pharmacies is fueling high drug costs. The Departm
Rheumatic fever and rheumatic heart disease continue to pose substantial challenges, particularly in low-income and middle-income countries, where they remain prevalent and disproportionately affect disadvantaged…
Despite significant biomedical advancements in various realms of oncology, the benefits of these developments are not equitably distributed, particularly in under-resourced settings. While much work…
Standard treatment with neoadjuvant nivolumab plus chemotherapy significantly improves outcomes in patients with resectable non–small-cell lung cancer (NSCLC). Perioperative treatment (i.e., neoadj…
In the first HPP insights post: Suzanne Wait discusses how navigating health policy and understanding what drives policy change are essential skills for future health…
Some information you come across about COVID-19 may be out of date or false. Learn about COVID-19 myths so you can bust them when you…
View this file, and add comments too.
archived 16 May 2024 20:04:02 UTC
Objective Despite evidence supporting the efficacy of sport injury prevention programmes (SIPPs) in adolescents, implementation of SIPPs in community settings is low. This review aims…
Apart from a global reduction in attendances during the COVID-19 pandemic,1 emergency departments continue to see growth in the presentations of children and young people…